A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension
Clinical trial NCT03738150 · COMPLETED
Trial details
- NCT number
- NCT03738150
- Sponsor
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-19
- Primary completion
- 2021-12-21
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.